Skip to the main content

Archives of Psychiatry Research : An International Journal of Psychiatry and Related Sciences, Vol. 57 No. 1, 2021.

Other

https://doi.org/10.20471/may.2020.57.01.09

Ansofaxine Hydrochloride

Vjekoslav Peitl orcid id orcid.org/0000-0003-4163-6411 ; Department of Psychiatry UHC Sestre milosrdnice, Zagreb, Croatia
Darko Vlahović orcid id orcid.org/0000-0002-4693-3450 ; Department of Psychiatry UHC Sestre milosrdnice, Zagreb, Croatia

Full text: english pdf 271 Kb

page 99-102

downloads: 873

cite

Abstract

Ansofaxine hydrochloride (LY03005; LPM570065) is a triple reuptake inhibitor that inhibits serotonin, dopamine and norepinephrine reuptake. This novel triple reuptake inhibitor is a carboxylic acid ester prodrug of desvenlafaxine. It is currently under development for the treatment of major depressive disorder - a frequent and heterogeneous disorder induced by a complex pattern of genetic, epigenetic, developmental, and environmental factors.

Keywords

Ansofaxine; Antidepressant

Hrčak ID:

245985

URI

https://hrcak.srce.hr/245985

Publication date:

20.11.2020.

Visits: 1.752 *